Eli Lilly's LLY -0.28% Get Free Report short percent of float has fallen 3.96% since its last report. The company recently reported that it has 7.71 million shares sold short, which is 0.97% of all ...

Eli Lilly's weight loss drugs, especially Zepbound and Mounjaro, have driven impressive revenue growth. Click here to read an ...

In the most recent trading session, Eli Lilly (LLY) closed at $771.75, indicating a -3.45% shift from the previous trading day.

Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...

On June 23, Eli Lilly and Company (NYSE:LLY) declared a quarterly dividend of $1.50 per share, which was in line with its ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

The average brokerage recommendation (ABR) for Lilly (LLY) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...

Whether for income or day trading, these ETFs are more complex and potentially risky products than they first appear. Buyer ...

The economy is struggling between maintaining stable prices and ensuring high employment. The Federal Reserve is under ...

Alexandria Real Estate secures a record lease of 466,598 SF in San Diego amid a softening market. Click for my updated look ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.